By Marie Rosenthal, MS
The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the chikungunya vaccine (Ixchiq, Valneva) for use in certain travelers and laboratory workers.
The ACIP recommended chikungunya vaccine for adults 18 years of age and older who are traveling to a country or territory where there is a chikungunya virus (CHIKV) outbreak. Additionally, it may be considered for people older than 65 who are traveling to a country or territory without an